Retraction notices

Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells

Type
Correction
Notice date
6/30/2022 0:00
Journal
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Notice DOI
10.1021/acs.jmedchem.2c00892
Original paper DOI
10.1021/acs.jmedchem.0c00694

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.